Literature DB >> 18186900

Unrelated HSCT in an adolescent affected by congenital erythropoietic porphyria.

Maura Faraci1, Giuseppe Morreale, Elio Boeri, Edoardo Lanino, Sandro Dallorso, Giorgio Dini, Francesca Scuderi, Amnon Cohen, Barbara Cappelli.   

Abstract

CEP is a rare inborn error of porphyrin-heme synthesis. Clinical manifestations can range from mild to severe and include erythrodontia, reddish-colored urine, and hemolytic anemia that can be mild or severe and may result in splenomegaly. Completely avoiding exposure to the sun is crucial. Attempts to reduce erythropoiesis and to lower circulating porphyrin levels by means of erythrocyte transfusions have been successful in reducing the expression of the disease. However, the complications of a chronic transfusion regimen are potentially severe. Successful bone marrow transplantation has been reported in CEP. We report a case of successful bone marrow transplantation and prolonged follow-up in an adolescent CEP patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18186900     DOI: 10.1111/j.1399-3046.2007.00842.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  3 in total

Review 1.  Therapeutic liver repopulation for phenylketonuria.

Authors:  Cary O Harding; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2010-05-22       Impact factor: 4.982

Review 2.  Congenital erythropoietic porphyria: Recent advances.

Authors:  Angelika L Erwin; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2018-12-27       Impact factor: 4.797

3.  Erythrodontia in congenital erythropoietic porphyria.

Authors:  Rashmi Bhavasar; G Santoshkumar; B Rahul Prakash
Journal:  J Oral Maxillofac Pathol       Date:  2011-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.